Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Pioglitazone Did Not Affect PPAR-Γ , STAT5 , HIF2α and CITED2 Gene Expression in Chronic Myeloid Leukemia Patients with Deep Molecular Response

Ana Beatriz Pascoal Lopes, Eliana C Miranda, PhD, Valquíria Mariane Oliveira Póvoa, Bruna Rocha Vergílio, Graziele Cristina Pavan Furlin, Marcia Torresan Delamain, MD, Gislaine Borba Duarte, MD, Carmino Antonio Souza, MD PhD, Erich V De Paula, MD PhD, Katia B Pagnano, MD PhD

Blood (2019) 134 (Supplement_1): 1637.

https://doi.org/10.1182/blood-2019-128265

Published: 2019

Journal Articles

Effect of Metabolic Reprogramming on the Biological Activity of Acute Myeloid Leukemia Cells

Tongyuan Liu, MD, Dengju Li, MD, Jianfeng Zhou, PhD

Blood (2018) 132 (Supplement 1): 5227.

https://doi.org/10.1182/blood-2018-99-115654

Published: 2018

Journal Articles

Real Life Evaluation of Efficacy and Safety of Bosutinib Therapy in Chronic Myeloid Leukemia Patients

Blood (2018) 132 (Supplement 1): 3021.

https://doi.org/10.1182/blood-2018-99-113427

Published: 2018

Journal Articles

The Impact of Diabetes Mellitus As Comorbid Condition, in Patients with Lower-Risk Myelodysplastic Syndromes (MDS)— a Study of the European Leukemianet-Based MDS (EUMDS) Registry

Blood (2017) 130 (Supplement 1): 4264.

https://doi.org/10.1182/blood.V130.Suppl_1.4264.4264

Published: 2017

Journal Articles

Metformin and the Incidence of Lymphoid Malignancies in Patients with Type 2 Diabetes

Adi J. Klil-Drori, MD, Hui Yin, MSc, Michael N. Pollak, MD, Laurent Azoulay, PhD

Blood (2017) 130 (Supplement 1): 1497.

https://doi.org/10.1182/blood.V130.Suppl_1.1497.1497

Published: 2017

Journal Articles

A Genetic Risk Score for Insulin Resistance Identify Patients with Chronic Myeloid Leukemia, Treated with Nilotinib, Developing Diabetes

Bruno Martino, Claudia Labate, DSC, Caterina Alati, MD, Domenica Ielo, DSC, Carmelo Laganà, MD, Francesca Ronco, Corrado Mammì, MD

Blood (2016) 128 (22): 3098.

https://doi.org/10.1182/blood.V128.22.3098.3098

Published: 2016

Journal Articles

Acute Promyelocytic Leukemia: An Unsual Presentation

Mary Kay Vaske, MD, Adeola Tomi-Olugbodi, MD, Indumathy Varadarajan, MD, J. Steve Hou, MD

Blood (2015) 126 (23): 4977.

https://doi.org/10.1182/blood.V126.23.4977.4977

Published: 2015

Journal Articles

Maintenance of mouse hematopoietic stem cells ex vivo by reprogramming cellular metabolism

Xia Liu, Hong Zheng, Wen-Mei Yu, Todd M. Cooper, Kevin D. Bunting, Cheng-Kui Qu

Blood (2015) 125 (10): 1562–1565.

https://doi.org/10.1182/blood-2014-04-568949

Published: 2015

Includes: Supplemental data

Journal Articles

Erosion Of The Chronic Myeloid Leukemia Stem Cell Pool By PPARγ Agonists

Stephane Prost, Francis Relouzat, Marc Spenchian, Gérald Massonnet, Jean-Paul Beressi, Els Verhoeyen, Benjamin Maneglier, Sylvie Castaigne, Christine Chomienne, Stany Chretien, Philippe Rousselot, Philippe Leboulch, PhD

Blood (2013) 122 (21): 5197.

https://doi.org/10.1182/blood.V122.21.5197.5197

Published: 2013

Journal Articles

Incidence of Hyperglycemia by 3 Years in Patients (Pts) with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated with Nilotinib (NIL) or Imatinib (IM) in ENESTnd

Rea Delphine, MD, PhD, Jean-francois Gautier, Massimo Breccia, Giuseppe Saglio, MD, Timothy P. Hughes, MD, MBBS, Hagop M. Kantarjian, MD, Charisse Kemp, Haitao Gao, Carmen Piccolo, MD, Richard A. Larson, MD, Andreas Hochhaus, MD

Blood (2012) 120 (21): 1686.

https://doi.org/10.1182/blood.V120.21.1686.1686

Published: 2012

Journal Articles

Regulation of Platelet Procoagulant Activity by Mitochondrial Calcium Influx

HyoJung Choo, PhD, Shawn M Jobe, MD, PhD

Blood (2011) 118 (21): 2193.

https://doi.org/10.1182/blood.V118.21.2193.2193

Published: 2011

Journal Articles

Safety and Efficacy of Frontline Nilotinib (Nb) for Chronic Phase (CP) Chronic Myeloid Leukemia (CML) in Diabetic Patients (pts)

Mahran Shoukier, Hagop M. Kantarjian, Elias Jabbour, Alfonso Quintas-Cardama, Zeev Estrov, Tapan Kadia, Gautam Borthakur, Guillermo Garcia-Manero, Steven M. Kornblau, Elizabeth M Burton, Susan O'Brien, Jorge E Cortes

Blood (2011) 118 (21): 2764.

https://doi.org/10.1182/blood.V118.21.2764.2764

Published: 2011

Journal Articles

An Acidic Milieu Created In Myeloma-Osteoclast Interaction Enhances Tumor Growth, but Triggers Anti-Myeloma Activity of Reveromycin A, a Novel Anti-Resorptive Agent

Keiichiro Watanabe, DDS, Masahiro Abe, MD, PhD, Qu Cui, MD, Makoto Kawatani, PhD, Masahiro Hiasa, DDS, PhD, Ayako Nakano, MD, PhD, Tadashi Jinno, MD, Takeshi Harada, MD, Shiro Fujii, MD, Shingen Nakamura, MD, Hirokazu Miki, MD, Kumiko Kagawa, MD, Kyoko Takeuchi, MD, PhD, Shuji Ozaki, MD, PhD, Eiji Tanaka, DDS, PhD, Hiroyuki Osada, PhD, Toshio Matsumoto, MD, PhD

Blood (2010) 116 (21): 454.

https://doi.org/10.1182/blood.V116.21.454.454

Published: 2010

Journal Articles

Chronic Idiopathic Neutrophilia: Retrospective Analysis of Causes and Consequences

Rafael Arteta-Bulos, Fellow, MD, Alva B. Weir, III, MD, FACP, James Lewis, MD

Blood (2010) 116 (21): 4717.

https://doi.org/10.1182/blood.V116.21.4717.4717

Published: 2010

Journal Articles

AMP-Dependent Kinase/mTOR Complex 1 Signaling In T-Cell Acute Lymphoblastic Leukemia: Therapeutical Implications

Cecilia Grimaldi, BS, Francesca Chiarini, PhD, Francesca Ricci, BS, Pierluigi Tazzari, MD, Michela Battistelli, PhD, Elisabetta Falcieri, MD, Andrea Pession, MD, PhD, James McCubrey, PhD, Alberto M. Martelli, MD

Blood (2010) 116 (21): 3225.

https://doi.org/10.1182/blood.V116.21.3225.3225

Published: 2010

Journal Articles

“Non-Hodgkin's Lymphomas and Diabetes of Type 2 in Elderly Patients: Impact On Management in the Real Life”.

Stephane Moreau, Liliane Remenieras, Mohamed Touati, Marie Jose RAPP, Marie-Pierre Gourin, Frederica Bompart, Nicolas Weinbreck, Sophie Lefort, Dominique Devesa-Mansour, Jean Feuillard, Arnaud Jaccard, Dominique Bordessoule, MD, PhD

Blood (2009) 114 (22): 4998.

https://doi.org/10.1182/blood.V114.22.4998.4998

Published: 2009

Journal Articles

The Antidiabetic Biguanide Metformin Induces Growth Arrest in Multiple Myeloma Cells in Vitro, overcoming the Effect of Stromal Cells

Melissa G. Ooi, Douglas W. McMillin, Joseph M. Negri, Jake Delmore, Nikhil C. Munshi, Dharminder Chauhan, Teru Hideshima, Paul G. Richardson, Constantine S. Mitsiades, Kenneth C. Anderson, Nicholas Mitsiades

Blood (2008) 112 (11): 2652.

https://doi.org/10.1182/blood.V112.11.2652.2652

Published: 2008

Journal Articles

Autologous Bone Marrow Transplant for Human Diabetes Mellitus.

Jose E. Novoa, MD, Maria A. Medina, AEP, Felipe Gordillo, MD, Jorge Ravera, MD, Carlos Olivet, MD

Blood (2007) 110 (11): 4060.

https://doi.org/10.1182/blood.V110.11.4060.4060

Published: 2007

Journal Articles

Long-Term Effects of Combined Chelation Therapy on Glucose Metabolism of Thalassemic Patients.

Kalistheni Farmaki, Nicholas Angelopoulos, Vasilios Berdoukas, Ioanna Tsoumari, Christina Pappa, Kiki Pappagianni

Blood (2007) 110 (11): 2770.

https://doi.org/10.1182/blood.V110.11.2770.2770

Published: 2007

Journal Articles

Hypolipemiant besides Antileukemic Effect of Imatinib Mesylate (Case Report).

Radu Bucur Gologan, MD, PhD, Gabriela Constantinescu, MD, Daniela Georgescu, MD, Daniela Ostroveanu, MD,PhD, Didona Vasilache, MD, Camelia Dobrea, MD, Daniela Iancu, MD, Viola Popov, MD

Blood (2006) 108 (11): 4832.

https://doi.org/10.1182/blood.V108.11.4832.4832

Published: 2006

NARROW

Pioglitazone Did Not Affect PPAR-Γ , STAT5 , HIF2α and CITED2 Gene Expression in Chronic Myeloid Leukemia Patients with Deep Molecular Response

Effect of Metabolic Reprogramming on the Biological Activity of Acute Myeloid Leukemia Cells

Real Life Evaluation of Efficacy and Safety of Bosutinib Therapy in Chronic Myeloid Leukemia Patients

The Impact of Diabetes Mellitus As Comorbid Condition, in Patients with Lower-Risk Myelodysplastic Syndromes (MDS)— a Study of the European Leukemianet-Based MDS (EUMDS) Registry

Metformin and the Incidence of Lymphoid Malignancies in Patients with Type 2 Diabetes

A Genetic Risk Score for Insulin Resistance Identify Patients with Chronic Myeloid Leukemia, Treated with Nilotinib, Developing Diabetes

Acute Promyelocytic Leukemia: An Unsual Presentation

Maintenance of mouse hematopoietic stem cells ex vivo by reprogramming cellular metabolism

Erosion Of The Chronic Myeloid Leukemia Stem Cell Pool By PPARγ Agonists

Incidence of Hyperglycemia by 3 Years in Patients (Pts) with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated with Nilotinib (NIL) or Imatinib (IM) in ENESTnd

Regulation of Platelet Procoagulant Activity by Mitochondrial Calcium Influx

Safety and Efficacy of Frontline Nilotinib (Nb) for Chronic Phase (CP) Chronic Myeloid Leukemia (CML) in Diabetic Patients (pts)

An Acidic Milieu Created In Myeloma-Osteoclast Interaction Enhances Tumor Growth, but Triggers Anti-Myeloma Activity of Reveromycin A, a Novel Anti-Resorptive Agent

Chronic Idiopathic Neutrophilia: Retrospective Analysis of Causes and Consequences

AMP-Dependent Kinase/mTOR Complex 1 Signaling In T-Cell Acute Lymphoblastic Leukemia: Therapeutical Implications

“Non-Hodgkin's Lymphomas and Diabetes of Type 2 in Elderly Patients: Impact On Management in the Real Life”.

The Antidiabetic Biguanide Metformin Induces Growth Arrest in Multiple Myeloma Cells in Vitro, overcoming the Effect of Stromal Cells

Autologous Bone Marrow Transplant for Human Diabetes Mellitus.

Long-Term Effects of Combined Chelation Therapy on Glucose Metabolism of Thalassemic Patients.

Hypolipemiant besides Antileukemic Effect of Imatinib Mesylate (Case Report).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only